Trial intelligence / Profile preview

Nicotine PK and Subjective Effects of 9 Investigational Nicotine Pouches in Adult Smokers

NCT07476144Phase 1Active, not recruiting

Start
Jan 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Phase 1, randomised trial of nicotine inhaler (12 arms). Primary endpoints: Investigational Product nicotine pharmacokinetics and abuse liability and Characterize nicotine PK Parameters. Started Jan 2026; status: active, not recruiting.

02

Drugs

nicotine inhaler

Beyond the preview

Go deeper on NCT07476144.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07476144.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call